Jordi Rodón Ahnert

Dr Rodón received his MD and PhD from the Universitat Autonoma de Barcelona and pursued postgraduate medical training at the Vall d’Hebron University Hospital. Dr Rodón spent two years at the Advanced Drug Development program at the Institute for Drug Development (IDD) in San Antonio, Texas, and completed his training in drug development in ICT as a senior clinical research fellow. He joined the MD Anderson faculty in 2016 as an Associate Professor in the Department of Investigational Cancer Therapeutics (ICT) with a joint appointment in the Department of Genomic Medicine. Dr Rodón also serves as Associate Medical Director for the Institute for Personalized Cancer Therapy and Clinical Co-Director of the Precision Oncology Decision Support Group.